Clydesdale Pharma Ltd
Private Limited Company · Tadley
ActiveUnited KingdomIncorporated 2019Private Limited Company
Financial position
Accounts to 2025-03-31 · GBP · company scope
Net assets
£1,632,223
Cash
£3,235
Turnover
—
Profit / loss
—
Current assets
£1,542,703
Creditors < 1 year
£625,105
Equity
£1,632,223
Average employees
9
Balance-sheet trend
GBP · companyFinancial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
| Reported figures | 2025-03-31GBP · company | 2024-03-31GBP · company | 2023-03-31GBP · company | 2022-03-31GBP · unknown | 2021-03-31GBP · unknown | 2020-03-31GBP · unknown |
|---|---|---|---|---|---|---|
| Balance sheet | ||||||
| Net assets | £1,632,223 | £915,629 | £913,805 | £19,364 | £8,550 | £4,121 |
| Equity | £1,632,223 | £915,629 | £913,805 | £19,364 | £8,550 | £4,121 |
| Assets | ||||||
| Fixed assets | £1,932,383 | £1,218,605 | £1,212,985 | £157,302 | £158,823 | — |
| Intangible assets | £1,906,284 | £1,192,679 | £1,184,951 | £155,781 | — | — |
| Property, plant & equipment | £26,099 | £25,926 | £28,034 | £1,521 | — | — |
| Current assets | £1,542,703 | £1,048,344 | £752,734 | £477,523 | £148,875 | £32,302 |
| Cash at bank | £3,235 | £1,601 | £7,730 | £144 | — | — |
| Debtors | £531,296 | £547,522 | £419,522 | £223,931 | — | — |
| Stock | £1,008,172 | £499,221 | £340,942 | £253,448 | — | — |
| Liabilities | ||||||
| Creditors within one year | £625,105 | £586,809 | £383,136 | £273,548 | £114,751 | £36,423 |
| Creditors after one year | £1,213,550 | £763,124 | £668,247 | £341,913 | £184,397 | — |
| Provisions | £4,208 | — | £531 | — | — | — |
| Net current assets | £917,598 | £461,535 | £369,598 | £203,975 | £34,124 | −£4,121 |
| Assets less current liabilities | £2,849,981 | £1,680,140 | £1,582,583 | £361,277 | £192,947 | £4,121 |
| People | ||||||
| Average employees | 9 | 5 | 1 | 1 | 1 | 1 |
| Source evidence | View filing | View filing | View filing | View filing | View filing | View filing |
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
6 outstanding chargesFloating · created 2025-03-14
—
OutstandingAll Assets · created 2024-01-15
—
OutstandingAll Assets · created 2023-09-07
—
OutstandingAll Assets · created 2023-07-06
—
OutstandingAll Assets · created 2022-07-06
—
OutstandingAll Assets · created 2021-05-17
—
OutstandingShow 3 satisfied / released
Unknown · created 2022-07-14 · satisfied 2024-03-07
—
SatisfiedAll Assets · created 2021-12-08 · satisfied 2024-03-07
—
SatisfiedKosei Pharma UK Ltd. (In Liquidation), Robert Christopher Keyes And Gareth Wyn Roberts As Joint Liquidators Of Kosei Pharma UK Ltd. (I
All Assets · created 2020-04-22 · satisfied 2020-06-03
—
Satisfied